Global Antiviral Drug Packaging Market Research Report 2026(Status and Outlook)

May 2026 | 144 pages | ID: GC51FFB6C189EN
Bosson Research

Abstracts

Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Antiviral Drug Packaging market size was estimated at USD 28320.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Antiviral Drug Packaging market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Antiviral Drug Packaging market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antiviral Drug Packaging market.

Global Antiviral Drug Packaging Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Avery Dennison Corporation
• E.I. du Pont de Nemours
• CCL Industries Inc
• BioCote
• Avient
• Mondi
• Biomaster
• BASF
• Lonza
• Takex Labo Co. Ltd
• Berry
• Lageen Tubes.

Market Segmentation (by Type)

• Rigid Plastic
• Flexible Blister Foils
• Others

Market Segmentation (by Application)

• Pharmaceuticals
• Healthcare

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Antiviral Drug Packaging Market

Overview of the regional outlook of the Antiviral Drug Packaging Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiviral Drug Packaging Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Antiviral Drug Packaging, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Antiviral Drug Packaging
1.2 Key Market Segments
  1.2.1 Antiviral Drug Packaging Segment by Type
  1.2.2 Antiviral Drug Packaging Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ANTIVIRAL DRUG PACKAGING MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Antiviral Drug Packaging Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Antiviral Drug Packaging Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ANTIVIRAL DRUG PACKAGING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Antiviral Drug Packaging Product Life Cycle
3.3 Global Antiviral Drug Packaging Sales by Manufacturers (2020-2025)
3.4 Global Antiviral Drug Packaging Revenue Market Share by Manufacturers (2020-2025)
3.5 Antiviral Drug Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antiviral Drug Packaging Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Antiviral Drug Packaging Market Competitive Situation and Trends
  3.8.1 Antiviral Drug Packaging Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Antiviral Drug Packaging Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ANTIVIRAL DRUG PACKAGING INDUSTRY CHAIN ANALYSIS

4.1 Antiviral Drug Packaging Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ANTIVIRAL DRUG PACKAGING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Antiviral Drug Packaging Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Antiviral Drug Packaging Market
5.7 ESG Ratings of Leading Companies

6 ANTIVIRAL DRUG PACKAGING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiviral Drug Packaging Sales Market Share by Type (2020-2025)
6.3 Global Antiviral Drug Packaging Market Size by Type (2020-2025)
6.4 Global Antiviral Drug Packaging Price by Type (2020-2025)

7 ANTIVIRAL DRUG PACKAGING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiviral Drug Packaging Market Sales by Application (2020-2025)
7.3 Global Antiviral Drug Packaging Market Size (M USD) by Application (2020-2025)
7.4 Global Antiviral Drug Packaging Sales Growth Rate by Application (2020-2025)

8 ANTIVIRAL DRUG PACKAGING MARKET SALES BY REGION

8.1 Global Antiviral Drug Packaging Sales by Region
  8.1.1 Global Antiviral Drug Packaging Sales by Region
  8.1.2 Global Antiviral Drug Packaging Sales Market Share by Region
8.2 Global Antiviral Drug Packaging Market Size by Region
  8.2.1 Global Antiviral Drug Packaging Market Size by Region
  8.2.2 Global Antiviral Drug Packaging Market Size by Region
8.3 North America
  8.3.1 North America Antiviral Drug Packaging Sales by Country
  8.3.2 North America Antiviral Drug Packaging Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Antiviral Drug Packaging Sales by Country
  8.4.2 Europe Antiviral Drug Packaging Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Antiviral Drug Packaging Sales by Region
  8.5.2 Asia Pacific Antiviral Drug Packaging Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Antiviral Drug Packaging Sales by Country
  8.6.2 South America Antiviral Drug Packaging Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Antiviral Drug Packaging Sales by Region
  8.7.2 Middle East and Africa Antiviral Drug Packaging Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ANTIVIRAL DRUG PACKAGING MARKET PRODUCTION BY REGION

9.1 Global Production of Antiviral Drug Packaging by Region(2020-2025)
9.2 Global Antiviral Drug Packaging Revenue Market Share by Region (2020-2025)
9.3 Global Antiviral Drug Packaging Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antiviral Drug Packaging Production
  9.4.1 North America Antiviral Drug Packaging Production Growth Rate (2020-2025)
  9.4.2 North America Antiviral Drug Packaging Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antiviral Drug Packaging Production
  9.5.1 Europe Antiviral Drug Packaging Production Growth Rate (2020-2025)
  9.5.2 Europe Antiviral Drug Packaging Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antiviral Drug Packaging Production (2020-2025)
  9.6.1 Japan Antiviral Drug Packaging Production Growth Rate (2020-2025)
  9.6.2 Japan Antiviral Drug Packaging Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antiviral Drug Packaging Production (2020-2025)
  9.7.1 China Antiviral Drug Packaging Production Growth Rate (2020-2025)
  9.7.2 China Antiviral Drug Packaging Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Avery Dennison Corporation
  10.1.1 Avery Dennison Corporation Basic Information
  10.1.2 Avery Dennison Corporation Antiviral Drug Packaging Product Overview
  10.1.3 Avery Dennison Corporation Antiviral Drug Packaging Product Market Performance
  10.1.4 Avery Dennison Corporation Business Overview
  10.1.5 Avery Dennison Corporation SWOT Analysis
  10.1.6 Avery Dennison Corporation Recent Developments
10.2 E.I. du Pont de Nemours
  10.2.1 E.I. du Pont de Nemours Basic Information
  10.2.2 E.I. du Pont de Nemours Antiviral Drug Packaging Product Overview
  10.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Product Market Performance
  10.2.4 E.I. du Pont de Nemours Business Overview
  10.2.5 E.I. du Pont de Nemours SWOT Analysis
  10.2.6 E.I. du Pont de Nemours Recent Developments
10.3 CCL Industries Inc
  10.3.1 CCL Industries Inc Basic Information
  10.3.2 CCL Industries Inc Antiviral Drug Packaging Product Overview
  10.3.3 CCL Industries Inc Antiviral Drug Packaging Product Market Performance
  10.3.4 CCL Industries Inc Business Overview
  10.3.5 CCL Industries Inc SWOT Analysis
  10.3.6 CCL Industries Inc Recent Developments
10.4 BioCote
  10.4.1 BioCote Basic Information
  10.4.2 BioCote Antiviral Drug Packaging Product Overview
  10.4.3 BioCote Antiviral Drug Packaging Product Market Performance
  10.4.4 BioCote Business Overview
  10.4.5 BioCote Recent Developments
10.5 Avient
  10.5.1 Avient Basic Information
  10.5.2 Avient Antiviral Drug Packaging Product Overview
  10.5.3 Avient Antiviral Drug Packaging Product Market Performance
  10.5.4 Avient Business Overview
  10.5.5 Avient Recent Developments
10.6 Mondi
  10.6.1 Mondi Basic Information
  10.6.2 Mondi Antiviral Drug Packaging Product Overview
  10.6.3 Mondi Antiviral Drug Packaging Product Market Performance
  10.6.4 Mondi Business Overview
  10.6.5 Mondi Recent Developments
10.7 Biomaster
  10.7.1 Biomaster Basic Information
  10.7.2 Biomaster Antiviral Drug Packaging Product Overview
  10.7.3 Biomaster Antiviral Drug Packaging Product Market Performance
  10.7.4 Biomaster Business Overview
  10.7.5 Biomaster Recent Developments
10.8 BASF
  10.8.1 BASF Basic Information
  10.8.2 BASF Antiviral Drug Packaging Product Overview
  10.8.3 BASF Antiviral Drug Packaging Product Market Performance
  10.8.4 BASF Business Overview
  10.8.5 BASF Recent Developments
10.9 Lonza
  10.9.1 Lonza Basic Information
  10.9.2 Lonza Antiviral Drug Packaging Product Overview
  10.9.3 Lonza Antiviral Drug Packaging Product Market Performance
  10.9.4 Lonza Business Overview
  10.9.5 Lonza Recent Developments
10.10 Takex Labo Co. Ltd
  10.10.1 Takex Labo Co. Ltd Basic Information
  10.10.2 Takex Labo Co. Ltd Antiviral Drug Packaging Product Overview
  10.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Product Market Performance
  10.10.4 Takex Labo Co. Ltd Business Overview
  10.10.5 Takex Labo Co. Ltd Recent Developments
10.11 Berry
  10.11.1 Berry Basic Information
  10.11.2 Berry Antiviral Drug Packaging Product Overview
  10.11.3 Berry Antiviral Drug Packaging Product Market Performance
  10.11.4 Berry Business Overview
  10.11.5 Berry Recent Developments
10.12 Lageen Tubes.
  10.12.1 Lageen Tubes. Basic Information
  10.12.2 Lageen Tubes. Antiviral Drug Packaging Product Overview
  10.12.3 Lageen Tubes. Antiviral Drug Packaging Product Market Performance
  10.12.4 Lageen Tubes. Business Overview
  10.12.5 Lageen Tubes. Recent Developments

11 ANTIVIRAL DRUG PACKAGING MARKET FORECAST BY REGION

11.1 Global Antiviral Drug Packaging Market Size Forecast
11.2 Global Antiviral Drug Packaging Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Antiviral Drug Packaging Market Size Forecast by Country
  11.2.3 Asia Pacific Antiviral Drug Packaging Market Size Forecast by Region
  11.2.4 South America Antiviral Drug Packaging Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Antiviral Drug Packaging by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Antiviral Drug Packaging Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Antiviral Drug Packaging by Type (2026-2035)
  12.1.2 Global Antiviral Drug Packaging Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Antiviral Drug Packaging by Type (2026-2035)
12.2 Global Antiviral Drug Packaging Market Forecast by Application (2026-2035)
  12.2.1 Global Antiviral Drug Packaging Sales (K MT) Forecast by Application
  12.2.2 Global Antiviral Drug Packaging Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Antiviral Drug Packaging Market Size by Type (M USD)
Table 4. Global Antiviral Drug Packaging Market Size by Application
Table 5. Antiviral Drug Packaging Market Size Comparison by Region (M USD)
Table 6. Global Antiviral Drug Packaging Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Antiviral Drug Packaging Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Antiviral Drug Packaging Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Antiviral Drug Packaging Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Packaging as of 2025)
Table 11. Global Market Antiviral Drug Packaging Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Antiviral Drug Packaging Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiviral Drug Packaging Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Antiviral Drug Packaging Sales by Type (K MT)
Table 27. Global Antiviral Drug Packaging Market Size by Type (M USD)
Table 28. Global Antiviral Drug Packaging Sales (K MT) by Type (2020-2025)
Table 29. Global Antiviral Drug Packaging Sales Market Share by Type (2020-2025)
Table 30. Global Antiviral Drug Packaging Market Size (M USD) by Type (2020-2025)
Table 31. Global Antiviral Drug Packaging Market Share by Type (2020-2025)
Table 32. Global Antiviral Drug Packaging Price (USD/KG) by Type (2020-2025)
Table 33. Global Antiviral Drug Packaging Sales (K MT) by Application
Table 34. Global Antiviral Drug Packaging Market Size by Application
Table 35. Global Antiviral Drug Packaging Sales by Application (2020-2025) & (K MT)
Table 36. Global Antiviral Drug Packaging Sales Market Share by Application (2020-2025)
Table 37. Global Antiviral Drug Packaging Market Size by Application (2020-2025) & (M USD)
Table 38. Global Antiviral Drug Packaging Market Share by Application (2020-2025)
Table 39. Global Antiviral Drug Packaging Sales Growth Rate by Application (2020-2025)
Table 40. Global Antiviral Drug Packaging Sales by Region (2020-2025) & (K MT)
Table 41. Global Antiviral Drug Packaging Sales Market Share by Region (2020-2025)
Table 42. Global Antiviral Drug Packaging Market Size by Region (2020-2025) & (M USD)
Table 43. Global Antiviral Drug Packaging Market Size by Region (2020-2025)
Table 44. North America Antiviral Drug Packaging Sales by Country (2020-2025) & (K MT)
Table 45. North America Antiviral Drug Packaging Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Antiviral Drug Packaging Sales by Country (2020-2025) & (K MT)
Table 47. Europe Antiviral Drug Packaging Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Antiviral Drug Packaging Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Antiviral Drug Packaging Market Size by Region (2020-2025) & (M USD)
Table 50. South America Antiviral Drug Packaging Sales by Country (2020-2025) & (K MT)
Table 51. South America Antiviral Drug Packaging Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Antiviral Drug Packaging Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Antiviral Drug Packaging Market Size by Region (2020-2025) & (M USD)
Table 54. Global Antiviral Drug Packaging Production (K MT) by Region(2020-2025)
Table 55. Global Antiviral Drug Packaging Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Antiviral Drug Packaging Revenue Market Share by Region (2020-2025)
Table 57. Global Antiviral Drug Packaging Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Antiviral Drug Packaging Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Antiviral Drug Packaging Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Antiviral Drug Packaging Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Antiviral Drug Packaging Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Avery Dennison Corporation Basic Information
Table 63. Avery Dennison Corporation Antiviral Drug Packaging Product Overview
Table 64. Avery Dennison Corporation Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Avery Dennison Corporation Business Overview
Table 66. Avery Dennison Corporation SWOT Analysis
Table 67. Avery Dennison Corporation Recent Developments
Table 68. E.I. du Pont de Nemours Basic Information
Table 69. E.I. du Pont de Nemours Antiviral Drug Packaging Product Overview
Table 70. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. E.I. du Pont de Nemours Business Overview
Table 72. E.I. du Pont de Nemours SWOT Analysis
Table 73. E.I. du Pont de Nemours Recent Developments
Table 74. CCL Industries Inc Basic Information
Table 75. CCL Industries Inc Antiviral Drug Packaging Product Overview
Table 76. CCL Industries Inc Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. CCL Industries Inc Business Overview
Table 78. CCL Industries Inc SWOT Analysis
Table 79. CCL Industries Inc Recent Developments
Table 80. BioCote Basic Information
Table 81. BioCote Antiviral Drug Packaging Product Overview
Table 82. BioCote Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. BioCote Business Overview
Table 84. BioCote Recent Developments
Table 85. Avient Basic Information
Table 86. Avient Antiviral Drug Packaging Product Overview
Table 87. Avient Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Avient Business Overview
Table 89. Avient Recent Developments
Table 90. Mondi Basic Information
Table 91. Mondi Antiviral Drug Packaging Product Overview
Table 92. Mondi Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Mondi Business Overview
Table 94. Mondi Recent Developments
Table 95. Biomaster Basic Information
Table 96. Biomaster Antiviral Drug Packaging Product Overview
Table 97. Biomaster Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Biomaster Business Overview
Table 99. Biomaster Recent Developments
Table 100. BASF Basic Information
Table 101. BASF Antiviral Drug Packaging Product Overview
Table 102. BASF Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BASF Business Overview
Table 104. BASF Recent Developments
Table 105. Lonza Basic Information
Table 106. Lonza Antiviral Drug Packaging Product Overview
Table 107. Lonza Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Lonza Business Overview
Table 109. Lonza Recent Developments
Table 110. Takex Labo Co. Ltd Basic Information
Table 111. Takex Labo Co. Ltd Antiviral Drug Packaging Product Overview
Table 112. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Takex Labo Co. Ltd Business Overview
Table 114. Takex Labo Co. Ltd Recent Developments
Table 115. Berry Basic Information
Table 116. Berry Antiviral Drug Packaging Product Overview
Table 117. Berry Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Berry Business Overview
Table 119. Berry Recent Developments
Table 120. Lageen Tubes. Basic Information
Table 121. Lageen Tubes. Antiviral Drug Packaging Product Overview
Table 122. Lageen Tubes. Antiviral Drug Packaging Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Lageen Tubes. Business Overview
Table 124. Lageen Tubes. Recent Developments
Table 125. Global Antiviral Drug Packaging Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Antiviral Drug Packaging Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Antiviral Drug Packaging Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Antiviral Drug Packaging Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Antiviral Drug Packaging Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Antiviral Drug Packaging Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Antiviral Drug Packaging Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Antiviral Drug Packaging Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Antiviral Drug Packaging Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Antiviral Drug Packaging Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Antiviral Drug Packaging Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Antiviral Drug Packaging Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Antiviral Drug Packaging Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Antiviral Drug Packaging Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Antiviral Drug Packaging Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Antiviral Drug Packaging Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Antiviral Drug Packaging Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Antiviral Drug Packaging
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiviral Drug Packaging Market Size (M USD), 2025-2035
Figure 5. Global Antiviral Drug Packaging Market Size (M USD) (2020-2035)
Figure 6. Global Antiviral Drug Packaging Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiviral Drug Packaging Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antiviral Drug Packaging Product Life Cycle
Figure 13. Antiviral Drug Packaging Sales Share by Manufacturers in 2025
Figure 14. Global Antiviral Drug Packaging Revenue Share by Manufacturers in 2025
Figure 15. Antiviral Drug Packaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Antiviral Drug Packaging Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antiviral Drug Packaging Revenue in 2025
Figure 18. Industry Chain Map of Antiviral Drug Packaging
Figure 19. Global Antiviral Drug Packaging Market PEST Analysis
Figure 20. Global Antiviral Drug Packaging Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antiviral Drug Packaging Market Share by Type
Figure 27. Sales Market Share of Antiviral Drug Packaging by Type (2020-2025)
Figure 28. Sales Market Share of Antiviral Drug Packaging by Type in 2025
Figure 29. Market Share of Antiviral Drug Packaging by Type (2020-2025)
Figure 30. Market Share of Antiviral Drug Packaging by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antiviral Drug Packaging Market Share by Application
Figure 33. Global Antiviral Drug Packaging Sales Market Share by Application (2020-2025)
Figure 34. Global Antiviral Drug Packaging Sales Market Share by Application in 2025
Figure 35. Global Antiviral Drug Packaging Market Share by Application (2020-2025)
Figure 36. Global Antiviral Drug Packaging Market Share by Application in 2025
Figure 37. Global Antiviral Drug Packaging Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antiviral Drug Packaging Sales Market Share by Region (2020-2025)
Figure 39. Global Antiviral Drug Packaging Market Size by Region (2020-2025)
Figure 40. North America Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antiviral Drug Packaging Sales Market Share by Country in 2024
Figure 43. North America Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antiviral Drug Packaging Market Size by Country in 2024
Figure 45. U.S. Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antiviral Drug Packaging Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antiviral Drug Packaging Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antiviral Drug Packaging Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antiviral Drug Packaging Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antiviral Drug Packaging Sales Market Share by Country in 2024
Figure 53. Europe Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antiviral Drug Packaging Market Size by Country in 2024
Figure 55. Germany Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antiviral Drug Packaging Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antiviral Drug Packaging Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antiviral Drug Packaging Market Size by Region in 2024
Figure 68. China Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antiviral Drug Packaging Sales and Growth Rate (K MT)
Figure 79. South America Antiviral Drug Packaging Sales Market Share by Country in 2024
Figure 80. South America Antiviral Drug Packaging Market Size and Growth Rate (M USD)
Figure 81. South America Antiviral Drug Packaging Market Size by Country in 2024
Figure 82. Brazil Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antiviral Drug Packaging Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antiviral Drug Packaging Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antiviral Drug Packaging Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antiviral Drug Packaging Market Size by Region in 2024
Figure 92. Saudi Arabia Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antiviral Drug Packaging Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antiviral Drug Packaging Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antiviral Drug Packaging Production Market Share by Region (2020-2025)
Figure 103. North America Antiviral Drug Packaging Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antiviral Drug Packaging Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antiviral Drug Packaging Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antiviral Drug Packaging Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antiviral Drug Packaging Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Antiviral Drug Packaging Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Antiviral Drug Packaging Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Antiviral Drug Packaging Market Share Forecast by Type (2026-2035)
Figure 111. Global Antiviral Drug Packaging Sales Forecast by Application (2026-2035)
Figure 112. Global Antiviral Drug Packaging Market Share Forecast by Application (2026-2035)